• 653 Citations
  • 15 h-Index
19962019
If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Simon Spazzapan is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 8 Similar Profiles
Breast Neoplasms Medicine & Life Sciences
Drug Therapy Medicine & Life Sciences
exemestane Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Tamoxifen Medicine & Life Sciences
Anthracyclines Medicine & Life Sciences
Fluorouracil Medicine & Life Sciences
Radiotherapy Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1996 2019

  • 653 Citations
  • 15 h-Index
  • 52 Article
  • 2 Chapter
  • 1 Review article
4 Citations (Scopus)

Adjuvant letrozole and tamoxifen alone or sequentially for postmenopausal women with hormone receptor-positive breast cancer: Long-term follow-up of the BiG 1-98 trial

BIG 1-98 Collaborative Group and the International Breast Cancer Study Group, Jan 10 2019, In : Journal of Clinical Oncology. 37, 2, p. 105-114 10 p.

Research output: Contribution to journalArticle

letrozole
Tamoxifen
Hormones
Breast Neoplasms
Disease-Free Survival
2 Citations (Scopus)

Post-neoadjuvant strategies in breast cancer: From risk assessment to treatment escalation

Pelizzari, G., Gerratana, L., Basile, D., Fanotto, V., Bartoletti, M., Liguori, A., Fontanella, C., Spazzapan, S. & Puglisi, F., Jan 1 2019, In : Cancer Treatment Reviews. 72, p. 7-14 8 p.

Research output: Contribution to journalReview article

Neoadjuvant Therapy
Breast Neoplasms
Drug Therapy
Cyclin-Dependent Kinase 6
Biomarkers

Eribulin Mesylate as Third or Subsequent Line Chemotherapy for Elderly Patients with Locally Recurrent or Metastatic Breast Cancer: A Multicentric Observational Study of GIOGer (Italian Group of Geriatric Oncology)-ERIBE

Leo, S., Arnoldi, E., Repetto, L., Coccorullo, Z., Cinieri, S., Fedele, M., Cazzaniga, M., Lorusso, V., Latorre, A., Campanella, G., Ciccarese, M., Accettura, C., Pisconti, S., Rinaldi, A., Brunetti, C., Raffaele, M., Coltelli, L., Spazzapan, S., Fratino, L., Petrucelli, L. & 1 others, Biganzoli, L., Jan 1 2018, (Accepted/In press) In : Oncologist.

Research output: Contribution to journalArticle

eribulin
Geriatrics
Observational Studies
Geriatric Assessment
Breast Neoplasms
1 Citation (Scopus)

Open-label randomised phase III trial of vinflunine versus an alkylating agent in patients with heavily pretreated metastatic breast cancer

Cortes, J., Perez-Garcia, J., Levy, C., Gómez Pardo, P., Bourgeois, H., Spazzapan, S., Martínez-Jañez, N., Chao, T. C., Espié, M., Nabholtz, J. M., Farré, X. G., Beliakouski, V., Garciá, J. R., Holgado, E. & Campone, M., Apr 1 2018, In : Annals of Oncology. 29, 4, p. 881-887 7 p.

Research output: Contribution to journalArticle

Alkylating Agents
Breast Neoplasms
Asthenia
Drug Therapy
Survival

Radical radiation therapy for oligometastatic breast cancer: Results of a prospective phase II trial

Trovo, M., Furlan, C., Polesel, J., Fiorica, F., Arcangeli, S., Giaj-Levra, N., Alongi, F., Del Conte, A., Militello, L., Muraro, E., Martorelli, D., Spazzapan, S. & Berretta, M., Jan 2018, In : Radiotherapy and Oncology. 126, 1, p. 177-180 4 p.

Research output: Contribution to journalArticle

Radiotherapy
Breast Neoplasms
Intensity-Modulated Radiotherapy
Disease-Free Survival
Radiosurgery